Gene · 2046
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer. | Front Cell Dev Biol | 2022 | 35309935 | PubTator, text mining | PubMed |
| Recent progress in the imaging of c-Met aberrant cancers with positron emission tomography. | Med Res Rev | 2022 | 35292998 | PubTator, text mining | PubMed |
| Prediction of the Active Components and Possible Targets of Xanthii Fructus Based on Network Pharmacology for Use in Chronic Rhinosinusitis. | Evid Based Complement Alternat Med | 2022 | 35287308 | PubTator, text mining | PubMed |
| Molecular mechanism and candidate biomarkers of morphine for analgesia and addiction effects. | Ann Transl Med | 2022 | 35282113 | PubTator, text mining | PubMed |
| Systematic understanding of anti-tumor mechanisms of Tamarixetin through network and experimental analyses. | Sci Rep | 2022 | 35273218 | PubTator, text mining | PubMed |
| Exosomes in multiple myeloma: from bench to bedside. | Blood | 2022 | 35271699 | PubTator, text mining | PubMed |
| The EPH/Ephrin System in Colorectal Cancer. | Int J Mol Sci | 2022 | 35269901 | PubTator, text mining | PubMed |
| Aldehyde Dehydrogenase 2 as a Therapeutic Target in Oxidative Stress-Related Diseases: Post-Translational Modifications Deserve More Attention. | Int J Mol Sci | 2022 | 35269824 | PubTator, text mining | PubMed |
| JAK2-Mediated Phosphorylation of Stress-Induced Phosphoprotein-1 (STIP1) in Human Cells. | Int J Mol Sci | 2022 | 35269562 | PubTator, text mining | PubMed |
| The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility. | Sci Rep | 2022 | 35264657 | PubTator, text mining | PubMed |
| Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses. | Immunity | 2022 | 35263569 | PubTator, text mining | PubMed |
| Multifunctional, Multivalent PIC Polymer Scaffolds for Targeting Antigen-Specific, Autoreactive B Cells. | ACS Biomater Sci Eng | 2022 | 35259296 | PubTator, text mining | PubMed |
| Protein tyrosine kinase Abl promotes hepatitis C virus particle assembly via interaction with viral substrate activator NS5A. | J Biol Chem | 2022 | 35257746 | PubTator, text mining | PubMed |
| Integrated Design of a Membrane-Lytic Peptide-Based Intravenous Nanotherapeutic Suppresses Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2022 | 35246961 | PubTator, text mining | PubMed |
| Raynaud's Phenomenon: Reviewing the Pathophysiology and Management Strategies. | Cureus | 2022 | 35242466 | PubTator, text mining | PubMed |
| Effects of Androgen Excess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development. | Front Endocrinol (Lausanne) | 2022 | 35237237 | PubTator, text mining | PubMed |
| Mutation-specific reporter for optimization and enrichment of prime editing. | Nat Commun | 2022 | 35232966 | PubTator, text mining | PubMed |
| PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells. | Int J Mol Sci | 2022 | 35216506 | PubTator, text mining | PubMed |
| Metformin's Mechanism of Action Is Stimulation of the Biosynthesis of the Natural Cyclic AMP Antagonist Prostaglandylinositol Cyclic Phosphate (Cyclic PIP). | Int J Mol Sci | 2022 | 35216316 | PubTator, text mining | PubMed |
| Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids. | Pharmaceuticals (Basel) | 2022 | 35215250 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2046/papers?page=18